New insights into the mechanisms of gastric cancer multidrug resistance and future perspectives.
about
Discovery of the inhibitory effect of a phosphatidylinositol derivative on P-glycoprotein by virtual screening followed by in vitro cellular studiesUpregulation of autophagy-related gene-5 (ATG-5) is associated with chemoresistance in human gastric cancerCD44v6 Monoclonal Antibody-Conjugated Gold Nanostars for Targeted Photoacoustic Imaging and Plasmonic Photothermal Therapy of Gastric Cancer Stem-like Cells.MACC1 decreases the chemosensitivity of gastric cancer cells to oxaliplatin by regulating FASN expression.Approaches and genetic determinants in predicting response to neoadjuvant chemotherapy in locally advanced gastric cancerActivating transcription factor 4 confers a multidrug resistance phenotype to gastric cancer cells through transactivation of SIRT1 expression.Regulation of β-catenin by t-DARPP in upper gastrointestinal cancer cells.ABCC1 is related to the protection of the distal nephron against hyperosmolality and high sodium environment: possible implications for cancer chemotherapyRhoGDI2 up-regulates P-glycoprotein expression via Rac1 in gastric cancer cells.Mechanism study of peptide GMBP1 and its receptor GRP78 in modulating gastric cancer MDR by iTRAQ-based proteomic analysis.High glucose promotes gastric cancer chemoresistance in vivo and in vitroBiased random walk model for the prioritization of drug resistance associated proteins.Regression of Gastric Cancer by Systemic Injection of RNA Nanoparticles Carrying both Ligand and siRNA.Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition.Characterization of site-specific glycosylation of secreted proteins associated with multi-drug resistance of gastric cancer.Ziyuglycoside II-induced apoptosis in human gastric carcinoma BGC-823 cells by regulating Bax/Bcl-2 expression and activating caspase-3 pathway.FAT4 hypermethylation and grade dependent downregulation in gastric adenocarcinoma.Fibroblast growth factor receptor 2: a therapeutic target in gastric cancer.Polymorphisms of XRCC1 and gastric cancer susceptibility: a meta-analysis.AP-2α reverses vincristine-induced multidrug resistance of SGC7901 gastric cancer cells by inhibiting the Notch pathway.Winding back Wnt signalling: potential therapeutic targets for treating gastric cancers.HNRNPC as a candidate biomarker for chemoresistance in gastric cancer.In vivo multimodality imaging of miRNA-16 iron nanoparticle reversing drug resistance to chemotherapy in a mouse gastric cancer model.Activation of EIF4E by Aurora Kinase A Depicts a Novel Druggable Axis in Everolimus-Resistant Cancer Cells.Anti-cancer activity of DHA on gastric cancer--an in vitro and in vivo study.Shugoshin1 enhances multidrug resistance of gastric cancer cells by regulating MRP1, Bcl-2, and Bax genes.CacyBP/SIP enhances multidrug resistance of pancreatic cancer cells by regulation of P-gp and Bcl-2.MicroRNA-34 dysregulation in gastric cancer and gastric cancer stem cell.Effects of 3β-acethyl tormentic acid (3ATA) on ABCC proteins activity.JWA regulates TRAIL-induced apoptosis via MARCH8-mediated DR4 ubiquitination in cisplatin-resistant gastric cancer cells.Genetic polymorphisms of XRCC1 gene and susceptibility to gastric cancer in Chinese Han population.MiR-30a Decreases Multidrug Resistance (MDR) of Gastric Cancer Cells.High level of serum AMBP is associated with poor response to paclitaxel-capecitabine chemotherapy in advanced gastric cancer patients.
P2860
Q28486121-B473194E-5ACF-4C02-93EF-A61720DB140DQ28543901-8F038ED4-22E2-45D8-A6BA-DB719FB0D6E9Q30407458-8577643F-A03F-483C-A840-C315DE5796CAQ33673940-894BBBCE-2E1A-4228-8ECA-C192E8478112Q33728359-3686268B-4DAC-43CE-805B-32259F15DA47Q34170941-811CD295-FBF1-4754-BF3A-8FEC5112F88CQ34785283-1C7D1FBD-3022-4419-9B74-1B7034C5E231Q34808344-E1D99497-3799-46C3-9756-2A4541FEE13FQ35505165-676CD4B2-ED70-4980-BA07-AF4A4000D4FBQ35604249-8FCB1AC2-078B-45F6-AD93-E733C033A990Q35628554-2C0EFB7D-F270-4EB8-B74D-2C74863B6ABEQ35679339-44412DB9-D96D-469C-B29E-5D0BE5E2C5AEQ35813076-9D5D6A5F-ED08-4887-B686-D2EF34E0F05CQ36548702-A6106B8D-03C6-4BC6-A3F2-322483D106DDQ37295326-79D983DF-CE69-43AE-A93F-0F7E25D3DA99Q37371534-2B9B5B05-455C-4F02-ABFE-5FECB1A95B16Q37716704-B5CBB7C7-4964-4A71-81A5-B4DB17A5BA8CQ38153418-AA35A0AB-BF47-4B8B-B61F-EA4F559C6B14Q38423185-4BB784B9-A31E-4E0F-AA5F-B76840232943Q38706254-4940B04E-DCAE-4DDA-98E1-6C25AE0A0227Q38751688-D8418338-9644-4B04-84B6-B21627226265Q38829125-A658B3FB-8649-4E5B-A606-5124FBFA77ADQ38946783-364F347F-D559-48E7-8AAB-5B50D2CB3DE2Q39028389-6658786F-8F5A-4382-9418-E37FC8C50383Q39116780-F92C9B2E-01BD-4A7C-A6A6-23A2998FB5A0Q39169792-26B08BA2-7EC6-4EAA-92AD-2B4E48B7EF69Q39184959-0E62032A-B012-4756-8575-E73B9C50009CQ39281229-E3CD5433-5B11-41FC-84A5-8A157AE6C658Q39307419-8D5E0899-88EF-4551-BA1D-130CFCA7BA90Q41228765-646735EB-2207-40FD-B528-65D2E2A3A018Q43953565-5C85EDDD-63B9-4FE9-BFA4-33BD3B7AAD0EQ50349138-5432E64D-E2E0-4A65-BE44-F1AF1B560F45Q53247758-C3AAE87E-2443-44B1-890E-A0DE4F91B4F0
P2860
New insights into the mechanisms of gastric cancer multidrug resistance and future perspectives.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New insights into the mechanis ...... tance and future perspectives.
@en
New insights into the mechanis ...... tance and future perspectives.
@nl
type
label
New insights into the mechanis ...... tance and future perspectives.
@en
New insights into the mechanis ...... tance and future perspectives.
@nl
prefLabel
New insights into the mechanis ...... tance and future perspectives.
@en
New insights into the mechanis ...... tance and future perspectives.
@nl
P2860
P356
P1433
P1476
New insights into the mechanis ...... tance and future perspectives.
@en
P2093
Daiming Fan
Dexin Zhang
P2860
P304
P356
10.2217/FON.10.21
P407
P577
2010-04-01T00:00:00Z